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Abstract
Alginate hydrogels provide desirable biocompatibility and material properties for various
biomedical applications, but are limited by the polymer's natural pore size. With the rise
of nanotechnology, the desired crosslinked pore size range of 30 nm to 100 nm has not
yet been achieved. This project aimed to develop a method to increase the pore size of
alginate-based hydrogels in a reproducible manner without compromising their
structural integrity. Experimental methods included altering alginate composition using
carboxymethyl cellulose or gelatin and inducing conformational changes via Mach-1TM
mechanical compression. Fluorescence microscopy was used to visualize the diffusion
of FITC-dextran weight markers and fluorescent polystyrene nanoparticles into the
microcapsules (d = 300 μm) and macrocapsules (d = 3 mm) for all experimental
conditions. Based on pilot experiments, altered alginate composition did not significantly
increase the pore size of alginate capsules for the modeled diffusivity range D = 1 x
10-14 m2/s to D = 1 x 10-15 m2/s. Mechanical compressions did not significantly affect the
porosity or diffusivity of alginate macrocapsules (p > 0.05) under all conditions for
Young’s moduli ranging from E = 76 kPa to E = 200 kPa. Based on image analysis
results, it could be hypothesized that molecular weight cutoff cutoff may be increased to
500 kDa following 10 successive compressions. Additional work to optimize fluorescent
microscopy methods and pore size manipulation methods is required for expanded use
of alginate capsules with emerging nanotechnologies.
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Introduction

Background

With the rise of modern medicine and an emphasis on prevention and treatment of
various diseases, hydrogels and nanotechnology have risen to the forefront of
biomedical research. Hydrogels, biomaterials with characteristics that closely mimic in
vivo conditions, are a promising technology that have applications in drug delivery,
therapeutics, diagnostics, and cell repair [1]. With a wide range of characteristics and
both natural and synthetic origins, hydrogels can be manipulated to meet a number of
biomedical needs [2]. Additionally, the advent of nanotechnology has greatly expanded
the biomedical field, enabling focus on a smaller scale [3]. With a growing concentration
on repairing, replacing, and regenerating the human body, there is now a demand for a
biocompatible material that can safely, efficiently, and sustainably encapsulate and
deliver a variety of biological and chemical payloads, including nanoparticles [4].

Alginate has been a particularly promising option because it is naturally biocompatible,
bioinert, low-cost, and has a structural composition that closely resembles in vivo
environments [5]. As a result, alginate is a strong candidate for applications ranging
from drug delivery and therapeutics to diagnostics and cell repair [1][5]. Alginate can
safely interact with a number of payloads including cells, chemical drugs, biological
molecules, and synthetic technology, while preserving the structural integrity and
functionality of these payloads to increase their therapeutic efficacy [4].
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Figure 1. Molecular Structure of Alginate. Mannuronic acid (M) and guluronic acid (G)
residues are labeled [1]

Review of Literature

Biomaterials have long been used to replace tissue lost to disease or trauma, and are
designed to be bioinert [5]. Hydrogels, a class of biomaterials, have emerged as
promising candidates for biomedical applications, including tissue engineering, and drug
delivery [2][5]. Hydrogels consist of crosslinked macromolecular networks, and have
varying properties depending on their intramolecular interactions and compositions,
altering their physical and chemical properties [5]. Tunable characteristics and the ability
to simulate in vivo conditions make hydrogels a desirable biomaterial, as most
hydrogels have impressive water retention capabilities, biocompatibility, porosity, and
comparable stiffnesses to that of soft tissue [2][5][6][7]. The porosity of these hydrogels
can determine their applications and efficacy in drug delivery or tissue engineering.
[2][7]. Applications in tissue engineering require hydrogels with pore sizes in the order of
microns. The techniques for pore manipulation on the micron-scale have been
7

established by previous research, and are less concerned with pore-size exclusion [2].
However, pores of several microns are too permeable for applications that require
controlled diffusion rates or pore-size exclusion.
Table 1. Diameters of Hydrogel-deliverable Payloads [8]

Payload

Diameter

Proteins

1-5 nm

Small Chemical Drugs

< 1 nm

Liposomes

20-50 nm

Exosomes

30-100 nm

Nanoparticles

<100 nm

Condensed Plasmid DNA

100 nm

Cells

>50 μm

Drug delivery systems that utilize hydrogel encapsulation allow for the delivery of the
therapeutic payload while protecting it from external conditions [7]. Payloads can consist
of proteins, which are most commonly around 1-5 nm in diameter, and nanoparticles,
defined to be particles <100 nm in diameter [8]. Diffusion of these payloads out of the
hydrogel can be modulated by hydrogel composition and the method of manufacturing.
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Critics of Current Literature

Hydrogels of interest for this study are hyaluronic acid, collagen, polyacrylamide, and
alginate, as all have been established as suitable for biomedical applications. Among
these hydrogels, alginate is arguably the best candidate for molecule payloads of 100
nm and smaller.

Hyaluronic acid (HA) is a proteoglycan that is one of the primary components of the
extracellular matrix and is desired for its resilience and hydrodynamic properties. The
porosity of HA is on the micron scale, giving it an advantage as a candidate for
biomaterial scaffolding in tissue engineering applications but disadvantaging it in the
realm of drug delivery and pore-size exclusion applications [6]. Collagen, a structural
protein of the ECM and another widely used polymer, also features porosity on the
micron scale and is likewise more suited for tissue engineering applications [9].

Polyacrylamide (PA) is a synthetic polymer that is biocompatible, inert, and features a
crosslinked nanopore size approximately 10 nm in diameter [10]. The manufacturing of
PA microcapsules is also well documented [10][11]. As a result, PA hydrogels seem to
be another suitable candidate. While the porosity of PA can accommodate most other
nanoparticle payloads, the methods to produce PA hydrogels and microcapsules yield
results with high variabilities of success. PA hydrogel and microcapsule production
requires a number of reagents, some of which are cytotoxic, and specific conditions to
ensure the quality of the capsules [10][11].

Alginate, a natural polymer, has a crosslinked pore range of 3-10 nm and can already
accommodate the diffusion of lower MW proteins (less than 70 kDa) and other small
molecules [5]. Established biofabrication methods include polyelectrolyte complexation
using atomization, inkjet bioprinting, electrostatic spraying, on-chip synthesis [12] and
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more recently nanoimprinting [13]. Alginate is also noncytotoxic [5], enabling its
expanded use in in vivo applications. Recent research on alginate hydrogels has also
shown that it can be treated with triazole-thiomorpholine dioxide (TMTD) to produce a
hydrogel that is completely nonimmunogenic [14]. Other hydrogels, such as HA and PA,
suffer from immunogenicity in vivo, which causes albumin to adhere to the surfaces of
these hydrogels [5] [14]. Albumin interactions with hydrogel microcapsule surfaces
could interfere with the effective porosity of the microcapsule by clogging the pores and
restricting diffusion into and out of
the microcapsule. Using
TMTD-alginate could allow for an
expanded role of in vivo alginate
hydrogels to deliver larger
payloads in consistent ways.
However, because the natural
pore size of alginate is
approximately 5 nm, it cannot
currently deliver therapeutic
payloads reliably or allow the
inward diffusion of molecules
other than proteins.

Figure 3. Molecular
structure of crosslinked
alginate using divalent
calcium ions. [1]
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Previous approaches have been pursued to tailor the pore sizes of hydrogels, such as
modifying polymer molecular weight, co-polymerization of two or more polymers, and
lyophilization [2][7]. For alginate, research has been conducted on modifying its pore
size within the micron scale for applications in tissue engineering, but little to no
research has been conducted in regard to the nanopore scale or on methods for reliable
and predictable nanopore size manipulation. Alginate pore size could be modulated by
using alginates of different molecular weights, adjusting the ratio of mannuronic (M) and
guluronic (G) acid residues and changing crosslinker concentration as well as
crosslinking time [1]. However, these processes have not yet been standardized to yield
predictable pore sizes. In addition, previous student research conducted at Santa Clara
University has also shown that mechanical compression is an effective method for
increasing nanopore size. [15][16] This conclusion still needs to be validated and
quantified in order to achieve predictable results moving forward and eventual
standardization [15][16].

Table 2. Pore Sizes of Hydrogels
Alginate

Collagen

Hyaluronic Acid

Polyacrylamide

5 nm [5]

>1 μm [6]

>1μm [9]

10 nm [10]
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Statement of Project Goals, Objectives, Expected Results

Alginate is a viable candidate for fulfilling the market need, but its crosslinked pore size
is too small for most applications. Additionally, there is currently no standard method for
uniformly manipulating pore size in alginate hydrogels. Therefore, our research has two
main objectives:

1) Increase molecular weight-cut off of alginate-based hydrogels without
causing damage to the structural integrity of the crosslinked structures
Our primary means of expanding the pore size to a range of 10 to 30 nm will be via
compression and relaxation cycles using the Mach-1TM mechanical testing device, which
have been shown to modify pore sizes [17]. For our purposes, damage to the structural
integrity of the microcapsules will be observations of microcrack formation on their
surface. Atomic force microscopy (AFM) and scanning electron microscopy (SEM) will
be used to verify that our microcapsule manipulations are not inducing such
degradation. If AFM and/or SEM images present any indication that our methods are
degrading the microcapsules, then new methods will be explored. If we find that
mechanical compression has severely compromised the structural integrity of the
microcapsules, we will explore two additional methods: lyophilization and the
manipulation of the ratio of residues constituting alginate. The former has been shown
to increase pore sizes. However, research has been limited to pore sizes in the micron
scale [2]. For the latter method, pore sizes can be expanded, but currently they cannot
be made uniform according to the desired pore size [1].

2) Devise a tool kit to test the incremental increase of pore size using
standardized nanoparticles
Fluorescent nanoparticles of varying sizes will be used to confirm modified pore sizes
and establish subsequent diffusion rates both into and out of alginate microcapsules.
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Such a kit would utilize pore size exclusion properties to indicate the uniformity in pore
size expansion as well. Achieving pore sizes in our desired range would optimally
situate such alginate microcapsules for the delivery of nanoparticles, small molecules,
and therapeutic payloads. Additionally, by standardizing a process of incremental pore
size expansion and subsequent diffusion rates, therapeutics in the form of polymers,
combined with inorganic materials, polymeric materials, and carbon based nanomaterial
[17] could be delivered in vivo in a time-delayed manner.
Backup Plans

3D Printing
If insurmountable difficulty arises using the physical and chemical modifiers to increase
pore size, we will turn to a 3D-printed solution. 3D-printed grids would act as artificial
pores, as they would be coated with a thin layer of minimally crosslinked alginate. Cells,
as well as nanoparticles or other small molecules, could easily be encapsulated inside
the gridded chamber for diagnostic applications or drug delivery purposes.

The material used to print the grids would be polylactic acid (PLA). PLA is a
biodegradable thermoplastic made from natural resources. It has a relatively low melting
temperature compared to other plastic filaments which allows it to be printed onto a
non-heated platform fairly easily [18]. Additionally, because of this low melting
temperature, PLA is less susceptible to sudden temperature shifts and subsequently
less prone to cracking or warping than other commonly used filaments [18]. A number of
studies have already used PLA in conjunction with alginate, predominantly for tissue
engineering solutions, indicating that the thermoplastic is a viable biocompatible option
[19]. The plastic grids would be printed using the Ultimaker 3D printer in the Santa Clara
University Maker Lab. This machine has a resolution of 20 microns, which is 1000x
larger than the nanometer range we are trying to achieve [20]. To produce artificial
pores in the 10-30 nanometer range, we would stack multiple PLA grids on top of each
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other to reduce the grid size until the desired pore size was reached. Adhesion between
layers of PLA is well-established in literature and easily accomplished [18]. Final pore
size could be verified via microscopic imaging. While this method would not modify the
pore size of the crosslinked alginate itself, it could be used to explore applications that
require nanoscale pores.

Lyophilization
Our second backup plan will be lyophilization, or freeze-drying. Lyophilized
alginate-based hydrogels have been used in tissue engineering applications, and their
lyophilization methods established [2]. Currently, collagen-chitosan hydrogels have
been shown to be biocompatible in vivo after lyophilization [2]. Porosity has also been
shown to have been manipulated by different lyophilization profiles, but most
manipulations have been performed for alginate scaffolds intended for tissue culturing
applications. As such, all pore size manipulations have occured at the micron range
[2][7]. Lyophilization may yield appropriate nanopore manipulations in smaller scale
alginate constructs, e.g. macrobeads and microbeads. Our alginate-based constructs
will be placed inside a lyophilizer, and rapidly cooled in order to bring its water content
from the liquid phase to the solid phase. Next, the pressure within the lyophilizer will be
decreased to dehydrate the hydrogel via sublimation, with the intention of increasing the
pore size [2]. The mechanical properties and the rate of degradation of the final
lyophilized product are most affected by the initial chemical composition and molecular
weight of the macrobeads.
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Significance of Project

Diagnostics
Encapsulation of cells in alginate membranes has a variety of in vivo and in vitro
diagnostic applications. Because alginate is a naturally-derived biocompatible material,
it does not elicit any immune response from its host. For this reason, various cell types
encapsulated in alginate microcapsules could be implanted into a host without fear of
degradation or antibody recognition [21]. This would allow for analysis of in vivo
functioning of various modified cell systems. Alginate encapsulation also has promising
in vitro applications for drug and other diagnostic testing. Due the matrices that exist in
the calcium crosslinked form of the material, encapsulated cells are able to engage in
extracellular interactions reminiscent of those that occur in vivo [22]. Biomembrane
encapsulation also increases the longevity of cell viability by facilitating nutrient diffusion
in and waste removal out of the capsule [22]. Alginate-encapsulated cells could be
exposed to a solution containing a particular drug; the rate of diffusion of the drug, and
consequently the effective concentration “seen” by the cell, could be manipulated based
on the pore size of the alginate. This would be valuable in determining the
time-dependent toxicity of a particular drug.

Drug Delivery
Drug delivery is arguably one of the most prevalent applications for alginate
microcapsules. With a growing pharmaceutical industry, there is a significant market for
safe, efficient, and cost-effective delivery methods. Nanoparticle-hydrogel hybrid
systems integrate two systems, nanoparticle therapies and hydrogel formulations to
address various biological and medical challenges [4]. Precise control over drug
quantity and release rate is advantageous over conventional drug release because of
enhanced bioavailability and minimized side effects [17]. There has been growing
interest in designing advanced hydrogels with tunable properties, especially porosity, to
optimally release nanoparticles for therapeutic benefit [17]. Because the average natural
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pore size of alginate (5 nm) is too small for most nanoparticles to diffuse through,
nanoparticle delivery methods involving alginate hydrogels rely on tuning degradation,
swelling, or dissolution to control drug release [17][23]. Being able to increase the pore
size of alginate in a predictable manner could introduce additional ways to modulate
diffusion rates out of nanoparticle-alginate systems. Combined with the relative ease of
manufacturing alginate microcapsules and the physical and chemical characteristics of
alginate, more efficient drug delivery systems can be developed to address more
biological and medical issues [17].

Wound Healing
Hydrogel pads are a novel form of wound dressing that come into direct contact with a
wound to promote healing. Hydrogels generally serve the dual purpose of maintaining
moisture in the wound area for faster wound repair, and absorbing wound exudate [24].
They also serve the purpose of releasing biomolecules, such as antibiotics to promote
wound repair [25]. Alginate hydrogels have been used for wound healing due to their
biocompatibility, and their absence of cytotoxicity. Applications using hydrogels
containing alginate alone, however, are restricted to wound repair that does not require
a long period of time, as they are degraded by absorbing alkaline media, such as wound
exudate [26]. Altering the porosity of alginate by coating the hydrogel with chitosan can
control the steady release of these biomolecules to counter the degradation caused by
absorbing wound exudate [27].

Bioenergy
Alginate has been applied in the bioenergy sector as a component for the production of
biodiesel. Biodiesel is an environmentally-friendly form of energy that has grown in
popularity [28]. One method of producing this renewable source of fuel is lipase
catalyzed transesterification, but some of the drawbacks of this method of biodiesel
production are the lack of stability of lipase during processing and the difficulty in
recycling lipase from the reaction mixture [28]. As a result, alginate has been used to
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physically entrap lipase to improve its stability [28]. Other biofuel production methods
using biomolecule entrapment involve alginate co-immobilization with other polymers,
adjusting the entrapment parameters necessary for efficient biofuel cell design [29].
Changing the porosity of alginate by mechanical means in a predictable way would
greatly improve manufacturing efficiency and simplicity by reducing the number of
reagents needed to produce the entrapping membrane and simplifying production
procedures. In addition, new applications involving larger entrapped biomolecules could
be developed to improve the efficiency of biofuel cells.

Desalination
Desalination processes produce drinkable water by removing salts from seawater,
saline groundwater, and wastewater at the cost of significant energy consumption [30].
Contributing to the energy costs of desalination is membrane fouling due to the buildup
of microbes, dissolved solutes and suspended solids [30]. Studying this phenomenon to
make desalination more energy-efficient is hampered by insufficient models of
membrane fouling [30]. Alginate is used as a model material to study membrane fouling,
but the variance in pore size measurements produces errors in biofouling models as a
result of estimations that vary by measurement technique [30]. Predictably producing
pore size would allow for more accurate determination of membrane parameters, like
water and salt fluxes across the membrane, in order to establish better membrane
fouling models [30]. Working towards these better models could allow for more efficient
desalination methods that may benefit those in water-scarce locations [30].
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Team and Project Management

Due to the limited research on porosity manipulation in alginate, the scope of the project
is relatively broad. As a result, team management and organization are imperative. We
have identified four project components (professional communication, literature search,
lab experimentation, and written communication) that have been further broken into
individual roles. A summary of team management and roles can be seen below:

Table 3. Team Project Management
Project Component

Role

Responsible Team Member

Professional Communication

Primary Contact

Jerard Madamba

Literature Search

Biofabrication

All Team

Mechanical Manipulation

All Team

Methacrylation

Natalie Ploof

Gelatin

Andrea Filler

Lyophilization

Jerard Madamba

UV

Jordan Levine

Lab Experimentation

All Techniques

All Team

Written Communication

Figures

Jerard Madamba

Citations

Natalie Ploof

Formatting

Jordan Levine

Submissions

Andrea Filler

Project Budget
The estimated budget for this project and amount provided by SCU’s School of
Engineering Undergraduate Programs Senior Design Grants is $1,930.30 (Appendix
18

1.1). The cost of our primary reagent, alginate, along with the materials to modify its
structure, are relatively inexpensive. A single experimental batch will only require 3 mL
of alginate to produce approximately 300,000 beads, resulting in a cost of about 2.5
cents per batch. The most costly reagents are the fluorescent size markers and
nanoparticles that will be used to test the size and uniformity of the pores following
modification, constituting just under 30% of the total budget. The components used to
manufacture the alginate microcapsule consistently, the flowmeter and needles, will
comprise about 50% of the overall budget, but will be crucial for producing accurate,
replicable results. Much of the high-cost equipment associated with mechanical
modification, crosslinking alternatives, and imaging are already present in the
Bioengineering laboratories and were not included in the project’s budget
considerations.

Project Timeline
This project will be completed over the course of 30 weeks. The first five weeks will be
devoted primarily to a review of relevant literature. From this literary research, unfulfilled
needs in the current field will be identified, as well as preliminary protocols for achieving
pore modification. A list of reagents and equipments will be assembled and ordered by
the end of Fall Quarter (week 10). Lab safety training and familiarization with basic lab
protocols will be completed by all team members during Fall Quarter as well.

Experimentation in lab will commence at the end of Fall Quarter with the majority of lab
work taking place during Winter. Any residual experimentation after week 20 will be
completed in the first few weeks of Spring Quarter. Data analysis will begin around the
third week of Winter Quarter and persist for a couple of weeks after the conclusion of
experimentation (week 24). As results from initial experimentation and method
optimizations are interpreted, development of standardized protocols will begin
(approximately week 17). These standardized protocol will be reviewed and tested
during the first two weeks of Spring Quarter. The final report summarizing research
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findings and including standardized protocols will be written primarily during Spring
Quarter and completed by week 28.

Details of Key Constraints

Our first design-related constraint concerns the structural integrity of the microcapsules
produced. To produce microcapsules that are uniformly spherical, both the
concentration of the alginate solution and the concentration of the crosslinking solution
must be high enough to maintain their structural integrity. As an example,
concentrations as low as 0.5% for sodium alginate solution and 0.5% for crosslinker
may not create hydrogel samples with adequate mechanical properties. If alginate
concentration and/or crosslinker concentration is too low, the resultant hydrogel may not
be manipulatable or may prematurely deform due to its fragile constitution. Therefore,
any attempts to reduce pore size by reducing the composition of alginate or its
crosslinker are limited by the minimum concentration of each reagent required for the
microcapsule to maintain its physical form.

Our second constraint concerns the accuracy of our measured pore sizes. Pore sizes of
the microcapsules will be estimated by the diameter of the molecular weight markers
that successfully diffuse through them. Experimental procedures for this project shall
involve FITC-dextran weight markers of varying molecular weights or nanoparticles
sized 26 nm and 47 nm, respectively. One limitation of this project is that pore sizes
besides those matched by these weight markers need to be extrapolated using
mathematical models. Therefore, we will not be able to accurately measure any pore
sizes between these two diameters. Rather, pore sizes of each hydrogel condition will
be estimated using mathematical extrapolation assuming steady state diffusion.
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Novel Approaches to the Problem

Our approach to increase the pore size of alginate involves the manipulation of alginate
hydrogel composition as well as post-production modifications. Review of current
literature on alginate hydrogels reveals that pore size characteristics for different
alginate hydrogel formulations are inconsistent throughout the field. Therefore, most
experimentation performed as part of this project is focused on characterizing the
porosity of different alginate-based hydrogel formulations and the effects of mechanical
manipulations on the pore sizes of these hydrogels. Experimentation shall proceed as
outlined in Figure 4.

Figure 4. Experimental Flowchart for Alginate Pore Size Modification

Experimentation shall begin with pilot experiments to determine the diffusion behavior of
FITC fluorescent markers across a hydrogel/saline interface. Hydrogels prepared for
this pilot experiment shall vary by alginate and crosslinker concentrations, and
production shall begin with the formation of macrobeads and slabs, followed by
microbeads for more comprehensive analysis. Based on qualitative analysis of
21

fluorescent microscopy, iterations of hydrogel composition and manufacturing methods
will be explored and the resultant findings characterized.

For the pilot experiment, qualitative evaluation of diffusion performance shall focus on
fluorescence microscopy to visualize the behavior of 70 kDa and 500 kDa weight
markers, which correspond to pore sizes of 5-6 nm and 10-11 nm, respectively [17].
Emphasis on these weight markers indicates successful pore size modification from the
baseline condition (3.0% w/v alginate crosslinked in 1.5% w/v CaCl2). Conditions in
which the weight markers successfully enter the hydrogel shall be prioritized for
iteration, as this would indicate achievement of target pore size. If all conditions in the
pilot experiment fail to allow the diffusion of the weight markers, or if the results of this
pilot experiment are ambiguous as to whether or not the weight markers successfully
diffuse, then alternative methods for hydrogel production will be explored, including, but
not limited to, hydrogel formulation, crosslinking time, crosslinking methods (e.g.
methacrylation, photocrosslinking), and post-crosslinking modification (e.g. mechanical
compression).

Experimentation past the pilot study shall then proceed using alginate microbeads
produced using atomization. Microbeads created for these experiments will be
approximately 300 μm in diameter and produced in large batch sizes, aiding in the
validation of uniformity among samples.

Supporting Analysis

Modification of alginate microbead pore size will be characterized using analysis of
fluorescent microscopy. Images of diffusion behavior taken at multiple timepoints will be
analyzed using appropriate software to quantify relative fluorescence units (RFU)
throughout a region encompassing an alginate/buffer interface. RFU values shall then
be incorporated into mathematical modeling to characterize the rate of diffusivity and
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pore sizes of the alginate hydrogel. In addition, SEM shall enable qualitative
visualization of the surface topography of the hydrogels to validate the structural
integrity of the alginate construct.

Expected Results

Success in reaching the aforementioned goal of increasing the pore size of alginate
hydrogels shall be validated using the following methods. First, visual verification by
fluorescence microscopy shall be used as a preliminary screen to determine successful
pore size manipulation. Based on the objectives previously outlined, success at this
stage will be defined as the entry or escape of 500 kDa FITC weight markers and 26 nm
polystyrene nanoparticles into or out of the alginate hydrogel. Second, SEM imaging
must demonstrate no indications of damage (i.e. microcracks) to the hydrogel, affirming
that all diffusive behavior is caused by intact micropores only. Third, analysis of
fluorescent microscopy images will be used to quantify diffusion at the hydrogel/buffer
interface using Fick’s First and Second Laws of Diffusion , assuming steady state
diffusion. Fick’s First Law (Equation 1) in 1D and Cartesian coordinates states:

J (x) =− D(

∂c(x)
∂x )

(1)

where J(x) is the flux at the hydrogel/buffer interface, D is the diffusion coefficient, and
∂c(x)
∂x is the concentration gradient. Fick’s Second Law (Equation 2) states:

∂c(x,t)
∂t
where

=−

∂2 c(x,t)
D( ∂x2 )

(2)

∂c(x,t)
is the rate of concentration change over a given distance and time, D is
∂t

the diffusion coefficient, and

∂2 c(x,t)
is the curvature of the concentration gradient.
∂x2

Fick’s Second Law can also be written in spherical coordinates (Equation 3) in order to
account for spatial scale assuming that diffusion in the angular dimensions is constant:

∂C m
∂t

=

∂C m
1 ∂
(D
r
e
r ∂r
∂r )

(3)
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Where

∂C m
∂t i s the rate of concentration change over a given distance and time, r is

the given distance over which diffusion occurs,
solute, and

De is the effective diffusivity of the

∂C m
∂r is the concentration change over the given distance. As

r

increases,

the rate of concentration change decreases, indicating that diffusion is more rapid over
shorter distances. Therefore, the diffusion of fluorescent dyes into microbeads will be
more easily visualized than diffusion of fluorescent dyes into macrobeads.
Concentration gradients will be determined using image analysis of fluorescent
microscopy in ImageJ. Calculated diffusion constants will be compared with existing
literature documenting associated diffusion constants for different micropore sizes.
Based on this mathematical modeling method, alginate hydrogel pore size will be
empirically extrapolated.
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Materials and Methods

Materials
Medium viscosity sodium-alginate, (listed as “alginic acid sodium salt from brown
algae,” A2033), anhydrous sodium chloride (793566), anhydrous calcium chloride
(C1016), 4 kDa FITC-dextran (FD40S), 70 kDa FITC-dextran (FD70S), and 500 kDa
FITC-dextran (FD500S) markers were purchased from Sigma Aldrich. 26 nm and 47 nm
polystyrene fluorescent beads were purchased from Thermo Fisher. Additionally, a
flowmeter was purchased from Omega (FL-9301). Finally a custom concentric atomizer
needle (inner gauge: 24G; outer gauge: 16G) was purchased from ramé-hart Instrument
Co. Additional materials including a Mach-1TM device from Biomomentum, Olympus
CKX53 fluorescent microscope, and syringe pump were already present in the SCU
Bioengineering laboratories.

Methods
Macrobead Formation [31]
Medium viscosity sodium alginate was dissolved in 0.9% NaCl solution and allowed to
spin for 24 hours. 2 mL of the alginate solution was then drawn up into a 10 mL
disposable syringe and a 22 G blunt needle was attached to the end of the syringe. The
alginate solution was then manually ejected from the syringe into a 60 mm petri dish
filled to half of its volume with CaCl2. Macrobeads were then allowed to crosslink for 30
minutes. Following a 30 minute crosslinking session, beads were rinsed with 12 mL of
0.9% NaCl three times. During each rinse, the NaCl solution was added to the 60mm
petri dish and was drained. Following the third wash, 12 mL of 0.9% NaCl was added to
the dish to prevent the beads from drying out.

Macrobeads were later fabricated using a syringe pump in order to improve uniformity
and replicability. Medium viscosity sodium-alginate was dissolved in 0.9% NaCl and
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allowed to spin for 24 hours. 2 mL of the alginate solution was then drawn up into a 10
mL disposable syringe and a blunt 22 G needle was attached to the end of the syringe.
The alginate solution was then ejected into a CaCl2 bath in a 60 mm petri dish from a
height of 7 cm at a constant rate of 1.0 mL/min. Beads were left to crosslink for 30
minutes. Following crosslinking, beads were rinsed three times in 12 mL allotments of
0.9% NaCl. After the third rinse, the beads were submerged in 12 mL of 0.9% NaCl to
prevent drying.
Atomization of Microbeads [1]
Following pilot experimentation, methodology switched to formation of microbeads to
improve bead uniformity, replicability, and biological relevance. These beads have
diameter around 300 microns. For microbead formation, sodium-alginate was dissolved
in 0.9% NaCl and allowed to spin for 24 hours. 1 mL of the alginate solution was pulled
up into a 3 mL lock-syringe and the syringe was then fitted with a custom atomizer
needle assembly with a concentric 24 G needle surrounded by a 16 G needle. The
assembly was then loaded into a syringe pump and the sodium-alginate mixture was
passed through the needle into a CaCl2 crosslinker bath from a height of 3 cm. The air
(FA) and liquid (FL) flow rates were adjusted to 1.5 mL/min and 1.0 mL/min, respectively
and beads were crosslinked for 1 hr. The microbeads were then washed three times in
excess 0.9% NaCl using a sieve. The beads were then transferred to a 60 mm petri dish
and submerged in 12 mL of 0.9% NaCl to prevent drying.
Slab Formation [1]
Medium viscosity sodium-alginate was dissolved in 0.9% NaCl and left to stir for 24
hours. The mixed alginate solution was then pipetted into 12-well plates, filling each well
approximately half way. The alginate slabs were allowed to dry to a thin film. Drying
time varied by slab diameter and thickness as well as slab composition (i.e. weight
percent of alginate). Once drying was complete, the wells were filled with CL. Slabs
were allowed to crosslink for 1 hour before being removed and placed into 60 mm petri
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dishes for rinsing. Each slab was rinsed three times in 12 mL of 0.9% NaCl each rinse.
After the third rinse, the slabs were submerged in 12 mL of 0.9% NaCl to prevent
drying.

Fluorescent Imaging
FITC fluorescent weight markers were dissolved in 0.9% NaCl at 1 mg/mL. Polystyrene
fluorescent beads were diluted in 0.9% NaCl at a 1:10 dilution to achieve a
concentration of 1 mg/mL. All fluorescent dyes were prepared in 5 mL batches.
Fluorescent microscopy and image capture were performed using the Olympus CKX53
microscope in conjunction with the Olympus cellSens platform. A blue filter block
(excitation 488 nm, emission 509 nm) to visualize fluorescent dyes.

Encapsulation
Fluorescent dyes were incorporated into alginate solutions prior to crosslinking in CaCl2.
The alginate-dye mixtures were then used to form macrobeads, microbeads, or slabs.
Following crosslinking, the alginate constructs were washed three times in 0.9% NaCl.
Each wash was transferred to and stored in 15 mL Eppendorf tube wrapped in
aluminum foil to prevent photobleaching. For image analysis, the washes were
transferred individually to 60 mm petri dishes.

Rapid Diffusion Tests
Alginate constructs were isolated on a microscope slide (slabs and microbeads) or
within a well plate (macrobeads). For isolation, sections of slabs were cut into circles
approximately 1 cm in diameter and physically secured to the microscope slide using
tape. Macrobeads were isolated in a flat-bottom 96-well plate (one bead per well) and
excess saline solution was pipetted out. Microbeads were isolated onto a microscope
slide by pipetting approximately 20 μL of microbead suspension onto the slide.
Microbead morphology prevented complete isolation of the constructs from the saline
buffer, so all fluorescent testing on microbeads was performed in saline buffer.
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After the alginate constructs were isolated, approximately 10-20 μL of fluorescent dye
was added adjacent to the slab, macrobead, or microbead suspension such that an
alginate-dye interface could be visualized by microscopy. Images were captured at 60
second intervals over 300 seconds using the cellSens platform, starting upon
application of the dye. Images were exported for analysis by ImageJ.

24-hour Incubation
Rapid diffusion methods were repeated as above, but alginate constructs were fully
submerged in fluorescent dyes for an additional 24 hours and reimaged to determine
long-term diffusion behavior. Images were exported for analysis by ImageJ.

Image Analysis
Qualitative Analysis of Microbead Diffusivity
ImageJ analysis was used to determine the relative fluorescence of the alginate
constructs at the beginning and end of the testing period (rapid diffusion or 24-hour
incubation). Images were exported into ImageJ and converted into grayscale. Gray
value profiles were plotted along a fixed line spanning the alginate-dye interface. Areas
of high fluorescence were indicated by higher gray values, while areas of low or no
fluorescence were indicated by lower gray values. Profiles for each image captured
during each experiment were generated and compiled for qualitative analysis. Diffusion
of the tested weight marker/fluorescent bead into the alginate construct was determined
based on qualitative comparison of each successive profile. Progressive increases in
gray value, relative to background, at the alginate-dye interface and in regions within the
construct corresponded with diffusion of the dye into the construct. Unsuccessful
diffusion of the dye corresponded with no noticeable increase, relative to background, in
gray value at the alginate-dye interface and in regions within the construct. Pore size
estimations were made based on the observed diffusive behavior of the weight
marker/fluorescent bead.
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Quantitative Analysis of Microbead Diffusivity
In addition to the qualitative results supplied by the gray value profiles, a quantitative
analysis was applied to microbead fluorescence images. For each compression
condition and weight marker, the elliptical tool in ImageJ was used to outline a single
representative microbead at t=0 minutes. This selection was copied to the image taken
under the same conditions at t=10 minutes (Figure 5). Using an ImageJ analysis
function, the mean gray values were calculated over the selected area for both
timepoints.

Figure 5. Mean gray value analysis of diffusion of 70 kDa weight markers into 2%
alginate microbeads.
Quantitative Analysis of Macrobead Diffusivity
The following measurements were obtained from macrobead diffusion images using the
cellSens platform: mean radial diffusion distance and estimated total bead
cross-sectional area. From the area, the assumed total bead radius was calculated. The
radius of the region where diffusion did not occur was calculated as the total radius
minus the radius of diffusion. Ratios of no-diffusion radii to total bead radii were
subsequently calculated.
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Figure 6. Diagram of Measurements for Calculations. Left: Measurements of radial distance of
diffusion (A) were obtained from microscope images. From the total area of the bead, the assumed total
radius of the bead was calculated (B). The radius of the region where diffusion did not occur (C) was
calculated as the total radius minus the radius of diffusion (B-A). Right: Fluorescent microscopy of
macrobead semisphere incubated in FITC-dextran. Measurements were taken using built-in tools in
cellSens. Distance A was averaged for each bead using multiple measurements per region.

Statistical Analysis
Microbeads
Mean gray values obtained from replicates of the same compression conditions and
weight marker incubations were averaged to obtain a single value. A Student’s t-test
was performed on these averaged values to determine if a significant difference in
mean gray value, or fluorescence intensity, existed between t=0 and t=600 seconds
timepoints for a given compression condition. An independent, two-sample t-test
assuming equal variance was performed:

t=

X1 − X2
sp

√

2
n

where

sp =

√

s2X + s2X
1

2

2

df = 2n − 2
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X n represents the average of the mean gray values for a single compression condition
at the t=0 seconds and t=10 minutes timepoints. Assuming equal variance, the term sp
indicates the pooled variance of both samples populations. The degrees of freedom, or
df, are used to calculate the t-statistic which is utilized to assess significance. The term
n represents the sample size. A 95% confidence interval was selected to determine the
a corresponding p-value from a t-statistic. If the p-value was less than 0.05, the null
hypothesis was rejected and compression was assessed to have a significant effect on
diffusion into alginate microbeads.

Macrobeads
A similar independent, two-sample t-test that assumed equal variance was performed
on the ratios of the radii over which diffusion did not occur to the total radii of the
macrobeads to compare the significance of compression on diffusivity. T-tests
comparing the effects of compression on the diffusivity of various weight markers into
macrobeads were performed for different lengths of incubation periods.

Example t-statistic calculation for testing significance of compressions on diffusion:

d.f . = 2 (# of samples) − 2

31

Pilot Testing
Composition Variations
A variety of AA and CL combinations were created in macrobead, microbead, and slab
morphologies. Fluorescence imaging was used to evaluate the relative pore size of
each composition condition using both FITC weight markers (4 kDa, 70 kDa, and 500
kDa) and polystyrene fluorescent beads (26 nm and 47 nm). Fluorescent testing was
general conducted using rapid diffusion tests and 24 hour incubation tests and ImageJ
analysis.

Table 4. Alginate and CaCl2 variations
% AA

% CaCl2 Crosslinker
0.25%

0.5%

1.5%

0.5%

-------

0.5% AA / 0.5% CL

0.5% AA / 1.5% CL

2%

2% AA / 0.25% CL

2% AA / 0.5% CL

2% AA / 1.5% CL

3%

-------

3% AA / 0.5% CL

3% AA / 1.5% CL

Alginate-Gelatin Mixtures
Alginate-Gelatin mixtures were created in varying ratios in macrobead, microbead, and
slab morphologies [32]. Fluorescence imaging was used to determine the relative pore
size of each mixture using both FITC weight markers (4 kDa, 70 kDa, and 500 kDa) and
polystyrene fluorescent beads (26 nm and 47 nm). Fluorescent testing was general
conducted using rapid diffusion tests and 24 hour incubation tests and ImageJ.

32

Table 5. Alginate-Gelatin Compositions [1.5 % CaCl2]
% Gelatin
% AA

0.5%

1.5%

0.5%

1:1 0.5% AA /
0.5% Gel

2:1 0.5% AA /
0.5% Gel

1:1 0.5% AA /
1.5% Gel

2:1 0.5% AA /
1.5% Gel

2%

1:1 2% AA /
0.5% Gel

2:1 2% AA /
0.5% Gel

1:1 2% AA /
0.5% Gel

2:1 2% AA /
1.5% Gel

Alginate-CMC Mixtures
Sodium alginate and carboxymethyl cellulose (CMC) were dissolved in 0.9% NaCl at a
3:1 ratio (2% w/v AA, 0.67% w/v CMC). Macrobeads and microbeads were
manufactured using aforementioned atomization methods. Fluorescence imaging was
used to determine the relative pore size of each mixture using both FITC weight
markers (4 kDa, 70 kDa, and 500 kDa) and polystyrene fluorescent beads (26 nm and
47 nm). Fluorescent testing was general conducted using rapid diffusion tests and 24
hour incubation tests and ImageJ.
Mach-1TM Compression
The following alginate compositions, 2% AA / 0.5% CL, 2% AA / 1.5% CL, 0.5% AA /
1.5% CL, and 2% AA / 2% Gel / 1.5% CL, were exposed to Mach-1TM compression to
mechanically break crosslinks in the hopes of expanding the average pore size. The
alginate constructs underwent compression/relaxation cycles using a ramp release
function or a stress relaxation with a consecutive move relative. During these
sequences, beads were compressed to 25% of their diameter at a constant rate of 0.5
m/s2. The compression was held for 1 or 5 seconds, then released at the same rate.
Beads were subjected to five or ten consecutive compressions with a find contact
function between each compression. Viscoelastic profiles were then generated and
analyzed to characterize material properties.
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Figure 7. Illustration of Mach-1TM set-up. Mach-1TM for mechanical compression is connected
to a PC and controlled using Mach-1TM Motion software. Samples are loaded onto the

Mach-1TM platform and compressed by a transducer. Transducer signals are sent to the PC for
data logging and profile plotting.

Figure 8. Sample Stress-Relaxation Plots of Crosslinked Alginate using Mach-1TM (from
BIOE 140L Winter 2016). The left chart is indicative of a single stress-relaxation cycle. The right
chart illustrates multiple rounds of stress-relaxation. Number of cycles will be optimized for each
alginate composition so as to minimize structural damage.
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Results

Morphology and physical behavior of different alginate constructs
Increased alginate and CaCl2 concentrations corresponded with increased opacity and
physical hardness, as determined by subjective observation. Alginate slabs took
approximately three days to manufacture at higher alginate and crosslinker
concentrations, but up to 7 days for lower concentrations. Additionally, slabs resulted in
inconsistent crosslinking due to variations in drying times. Lower alginate and
crosslinker concentrations also resulted in macro and microbeads with inconsistent
morphology. Beads manufactured with 0.5% sodium alginate and or 0.5% CaCl2 were

unable to hold a consistent spherical shape, especially under mechanical compression.
Atomized microbeads held mostly uniform shape with a diameter between 600 and 700
μm. Some beads were not spherical in shape, so beads that were considered to be
uniformly circular were chosen for analysis.

Figure 9. Morphology of Atomized Crosslinked Alginate Microbeads. Alginate microbeads shown are
incubated in 500 kDa FITC-dextran. Bead diameter: approximately 600 μm.
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Alginate-Gelatin macrobeads dropped into CaCl2 baths had flattened morphologies on
contact, with similar opacity profiles as pure alginate hydrogels. When atomized,
alginate-gelatin microbeads did not form individual microspheres, and instead gelled
into larger slabs, at the standardized atomization needle height and liquid and gas
flowrates. After atomization, individual alginate-gelatin microbeads were unable to be
discriminated under phase contrast microscopy. Alginate-CMC macrobeads formed
similarly to pure alginate hydrogels, but exhibited a higher observed physical hardness.

Radial Diffusivity Ratios for Macrobeads
Macrobeads (2% AA, 1.5% CaCl2) were incubated in 4kDa FITC-detxran dye for 60
minutes to allow for diffusion to occur. Radial diffusion distances of the fluorescent dye
into the bead interior at 60 minutes were averaged and compared to the baseline
fluorescence measured along the bead border at t=0. No significant difference in radial
diffusion distance of the 4 kDa weight marker was observed after 60 minutes. The effect
of mechanical compression on diffusion of the 4 kDa marker into alginate microbeads
was tested as well. Macrobeads were compressed five times using a ramp release
cycle facilitated by the Mach-1TM instrument. After each compression, a random sample
of beads were removed and incubated in fluorescent dye for 60 minutes. For each
compression condition, the ratio of the area over which diffusion occurred to the total
area of the bead was calculated for multiple beads. These values were compared to the
baseline ratios calculated for macrobeads that had experienced no compressions.
Mechanical compression of macrobeads were not shown to have a significant effect on
diffusion of the 4 kDa weight marker.

Similarly, macrobeads with the same chemical composition were incubated for 60
minutes in 500 kDa FITC-dextran dye. By performing a statistical analysis comparing
the mean radial diffusion distances of the fluorescent dye into the bead at t=0 and t=60
minutes, no significant increase in diffusion was observed over the hour-long incubation
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period. As with the 4 kDa marker, the effect of compression on diffusivity of 500 kDa
molecules into alginate macrobeads was tested. No significant effect on diffusion was
observed for any number of mechanical compressions between one and five successive
manipulations.

Alginate macrobeads mechanically compressed between one and five times were
additionally incubated in 26 nm and 47 nm polystyrene fluorescent beads separately for
60 minutes. Successive compressions were found to have no significant effect on the
distance of diffusion of either weight marker into the macrobead.
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Table 6: Confirmed Diffusion of Fluorescent Dyes in Macrobeads and
Microbeads, uncompressed and compressed

Alginate

Effective

Confirmed Diffusion

Confirmed Diffusion

(No Compression)

(w/ 5 Compressions)

P-Value

Construct

MWCO

Pore Size

Macrobeads

4 kDa

2 nm

No

No

0.82

70 kDa

6 nm

No

No

N/A*

500 kDa

11 nm

No

No

0.63

6,400

26 nm

No

No

0.71

47 nm

No

No

0.85

4 kDa

2 nm

Yes

Yes

N/A^

70 kDa

6 nm

Yes

Yes

N/A^

500 kDa

11 nm

No

Plausible

0.72

6,400

26 nm

No

Inconclusive

0.51

47 nm

No

No

0.89

2% AA, 1.5%
CaCl2

kDa
38,000
kDa

Microbeads
2% AA, 1.5%
CaCl2

kDa
38,000
kDa
*

Insufficient data

^

Confirmed diffusion based on literature review [31]
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ImageJ Analysis of Microbeads
Images of microbeads (2% AA, 1.5% CaCl2) incubated in all fluorescent dyes were
compared at t = 0 minutes and t = 10 minutes, with gray value profiles generated and
compared for each condition at these two timepoints. For all dye conditions at t = 0
minutes, all gray value profiles featured indentations that represent the bead interior.

For beads incubated in the 70 kDa FITC-dextran, these indentations became shallower
over a 10 minute period, and the gray values within the bead approached the
background gray value. There was no discernable difference in the gray value plot
behavior between uncompressed microbeads and the 5C and 10C microbeads
incubated in 70 kDa FITC-dextran. Similarly, there was no discernable difference in the
gray value plot behavior between microbeads incubated in 4 kDa FITC-dextran and
microbeads incubated in 70 kDa FITC-dextran.

For microbeads incubated in 500 kDa FITC-dextran, gray value plot behavior varied
between uncompressed and compressed bead conditions. At both 0C and 5C, the gray
value indentations did not increase appreciably relative to the background values. At
10C, the gray values in the region within the microbead appeared to increase relative to
background values. Similar behavior was documented for microbeads incubated in 26
nm PS, with a slight increase in gray value plots for all conditions, but no significant
change occurred with more compressions.

Microbeads incubated in 47 nm PS had no significant change in gray value plot from
time t = 0 minutes to t = 10 minutes.
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Figure 10. Gray value plots across alginate microbead diameter. Plots were generated using ImageJ
for images taken at 60 second intervals. High gray values correspond to high fluorescent intensity, while
low gray values correspond with low fluorescent intensity.

Mean gray values for a single microbead were calculated for each molecular weight
marker at t=0 and t=10 minutes following incubation. If diffusion of the weight marker
into the microbead were to occur, the mean gray value over the cross-sectional area of
the bead would be expected to increase over the 10 minute incubation period. In the
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500 kDa condition, the mean gray value decreased after 10 minutes in microbeads
exposed to 0, 5, and 10 compressions. However, following statistical analysis no
significant difference in gray values, and subsequently no inward diffusion of the weight
marker, was observed in any of the three compression conditions. Similarly, no
statistically significant difference in diffusion of the 26 nm and 47 nm weight markers
over the incubation period were observed at either 0, 5, or 10 compressions.

Figure 11. Change in mean gray value of cross-sectional area of alginate microbeads incubated in
various fluorescent weight markers. ImageJ was used to evaluate gray values over specific bead
areas. No significant differences in gray values over 10 minute weight marker incubation were observed
for any compression condition. Error bars represent standard deviation from the mean.
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Diffusion Modeling of Microbead Constructs
Based on the results of the observed microbead incubation in fluorescent dyes,
COMSOL models were generated, given what was observed in the incubation
experiments. Simple 2D models were generated with Dirichlet boundary conditions set
to match what was observed using the fluorescent microscope. Diffusivities of the bead
interior were determined using a parametric sweep and subjectively chosen to match
what was experimentally observed.
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Table 7. Estimated Microbead Diffusivities based
on COMSOL modeling
Condition

Estimated Diffusivity

0C/5C/10C, 70 kDa

4.0 x 10-11 m2/s

10C, 500 kDa

9.0 x 10-12 m2/s

Based on these simplified models, 1D profile plots of concentration over the diameter of
the bead were generated. These plots were similar in behavior to the gray value plots
obtained using ImageJ, where areas of lower fluorescent intensity or concentration is
the least at the center of the microbead.

Figure 13: 1D Concentration Profile Plots for 70 kDa and 500 kDa Microbead Models. Concentration
was plotted along the arc length of the diameter of a simulated microbead. Curves were drawn at 60
second intervals of the simulation.
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Viscoelastic Profiles for Macrobead Compressions

Figure 14. Recovery Time Graphs and Viscoelastic Profiles of Compressed Alginate Macrobeads.
Viscoelastic profiles were generated using data collected during Mach-1TM c
 ompressions. The Mach-1TM
device recorded time (s), position (m), and force (gf). Force (N), stress, and strain (Pa) were calculated.
A) Stress versus time graph for 2% AA / 1.5% CL beads subjected to five 1 s ramp release mechanism.
B) Stress versus strain graph for 2% AA / 1.5% CL beads subjected to five 1 s ramp release mechanism.
C) Stress versus time graph for 2% AA / 1.5% CL beads subjected to five five second long stress
relaxation mechanism followed by a move relative function. D) Stress versus strain graph for 2%AA /
1.5% CL beads subjected to five five second long stress relaxation mechanism followed by a move
relative function.
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Table 8. Material Properties of Compressed Alginate Microbeads
Number of

EStress Relaxation

ERamp Release

∆t (s)

Compressions

(kPa)

(kPa)

1

76.05

110.40

2.59

2

89.86

120.70

2.60

3

150.56

135.30

2.64

4

146.48

139.76

2.54

5

200.66

157.60

2.63

Discussion

Pilot testing revealed that several composition manipulations were unviable for eventual
experimentation. Alginate-gelatin mixtures were not examined due to inconsistent shape
and microbead gelation. Similarly, low alginate and crosslinker conditions yielded
inconsistent morphologies that were deemed unsuitable for investigation. High alginate
and crosslinker conditions, despite their consistent morphology, were also excluded
from investigation after pilot testing revealed restricted diffusivity at weight marker sizes
larger than 70 kDa. As a result, analysis and process optimization focused on
macrobeads and microbeads consisting of 2% AA, 1.5% CL, crosslinked for 30 minutes
(macrobeads) and 60 minutes (microbeads). This formulation was the most ideal for
manipulation and imaging purposes, as constructs fabricated under these conditions
yielded the most uniform and manipulable beads. Alginate slabs were not considered
for analysis due to the increased time of manufacturing, limited by drying time, which
was deemed to be impractical for diffusivity analysis.

45

ImageJ analysis of microbead diffusivities indicated that the molecular weight cutoff of
2% AA, 1.5% CL microbeads is 70 kDa uncompressed, and 500 kDa compressed 10
times, indicating that the pore size of these constructs is less than 6 nm and 11 nm,
respectively. For most 500 kDa FITC-dextran incubations, relative increases in gray
value within a microbead were not easily discriminated. After 10 compressions, the gray
value change after 10 minutes of incubation in the 500 kDa FITC-dextran became more
pronounced, suggesting an increase in the diffusivity of the microbead. Increases in the
diffusivity can be interpreted as an increase in the pore size of the alginate microbead.
Because the dye was able to penetrate further into the microbead after compressions it
is implied that the Stokes radius of the dye is less than the pore size at the membrane.
Therefore, the pore size of the alginate microbead must be greater than the 500 kDa
FITC-dextran after 10 compressions.

However, the gray value plots for the 500 kDa, 10C condition do not agree with
COMSOL modeling of the concentration change. COMSOL models suggest that after
10 minutes of incubation, the concentration of dye at the center of the bead is greater
than half of the background concentration. In comparison, gray value plots obtained
using ImageJ indicate that the amount of inward diffusion is not as great despite the
visual agreement between the model and the observed results. In order to reconcile the
differences between the simplified model generated in COMSOL and the images
captured using fluorescence microscopy, the generation of a calibration curve is
necessary. However, despite controls taken to minimize photobleaching, the generation
of a calibration curve to translate fluorescence to concentration was inconsistent. Lower
concentrations were difficult to obtain analogous gray values due to rapid
photobleaching. In addition, variation in real time incubation changed the relative
background fluorescence in each experiment, which may or may not correspond to
varying concentrations. As a result, optimization of the microbead incubation method is
necessary in order to mitigate the photobleaching of the fluorescent dye.
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Viscoelastic profiling assumed perfectly elastic behavior in order to determine
approximate Young’s modulus values over multiple compressions. Due to the
viscoelastic character of sodium alginate hydrogels, further analysis is needed to
determine precise values. Approximate values, however, suggest that the alginate
constructs experience strain hardening with consecutive compressions. This is seen
through the general increase in the Young’s modulus over the course of testing,
indicating that the construct is not weakening. Taking into account ImageJ analysis of
microbead diffusivities, despite the strain hardening of the alginate constructs, 10
ramp-release compressions appear to increase the molecular weight cutoff of these
alginate constructs to ≥ 500 kDa. However, due to time constraints and incomplete
optimization of compression data collection, viscoelastic profiles for 10C microbeads
were not obtained. As a result, it is unknown whether strain hardening continued to
occur beyond 5 compressions, or if strain softening occured post 5C. Strain softening
would correspond to the weakening of the bead and potential damage to the construct.
If a bead were to be damaged, microcracks on the surface of the microbead may
influence the molecular weight cutoff of the hydrogel, therefore skewing our dataset.
Further testing needs to be conducted to determine the exact effects of mechanical
manipulation on the molecular weight cutoff and, therefore, pore size of alginate
hydrogels. In addition, visual confirmation of bead topography post-compression is
necessary to determine whether compressions induce damage.
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Future Directions
Throughout experimentation, it was determined that the 60 minute incubation period for
macrobeads did not allow for adequate diffusion time in relation to the radial distances
of the beads. Therefore, in future experiments, longitudinal diffusion studies, or
experiments with incubation periods spanning up to four days, should be conducted to
observe diffusion behavior over longer periods of time.

In addition, several directions need to be explored in terms of mechanical compressions
and material characterization. Viscoelastic data needs to be analyzed using complex
moduli for more representative material characterization. Additionally, the number of
consecutive compressions should be increased in order to determine the ultimate
tensile strength of the given alginate constructs. Further research into varying
compression time and distance must also be conducted to determine effects on overall
porosity.

Additional manipulations may lead to the increase in pore size of alginate hydrogels.
Sodium citrate is a compound that reverses crosslinking in alginate based hydrogels.
Whether or not this has an appreciable effect on the pore size of alginate based
hydrogels has yet to be determined. Future studies may look into the optimization of
citrating alginate based hydrogels to tune pore size. Similarly, future work may look into
the effects of lyophilization on pore size. Lyophilization has been previously used to
influence the microporosity of alginate based hydrogels [2], so studies may be
conducted to determine how nanoporosity can be influenced by different lyophilization
profiles.
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Summary and Conclusion

Our project sought out to determine methods to increase the pore size of alginate based
hydrogels in order to expand its applications in the biomedical field. The primary
manipulations we analyzed were hydrogel composition, fabrication method, and
mechanical compressions, and we examined each manipulations’ effect on the effective
pore size of the resultant hydrogel construct. For the optimal hydrogel formulation (2%
AA, 1.5% CL), we found that mechanical compressions had a nonsignificant effect on
macrobead diffusivity. However, it may have had a significant effect on microbead
diffusivity. Future work still needs to be completed to determine exactly how mechanical
compressions affects bead integrity, and the intrinsic material properties of
alginate-based hydrogels. In addition, further test method optimization is necessary to
create comprehensive diffusion models to relate what is observed using fluorescent
microscopy methods to precise mathematical constants, to which pore size can be
related. While the desired goal of increasing the pore size to the 10-30 nm range was
not reached, we have set a foundation for future groups to continue exploring methods
to tune the porosity of alginate based hydrogels.
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Engineering Standards and Realistic Constraints

Manufacturability
The objectives of this project demand manipulation of natural properties of a
naturally-occurring material for primary use in biomedical applications. As such,
maintaining consistency when producing alginate hydrogel microcapsules with desired
pore sizes is essential to ensure replicable results in downstream applications of this
method. Method development should yield protocols that reliably produce alginate
hydrogel constructs with the target pore size throughout the batch. Additionally, if
uniformity of pore size is not achieved within a single microcapsule, calculated diffusion
rates will meaningless, thereby eliminating controlled drug delivery applications.

Economic
Considering the relative ease to produce alginate hydrogels, the methods developed by
this project should preserve the simplicity of existing protocols. Having simple protocols
that do not require specialized equipment (i.e. UV light sources for photocrosslinking,
lyophilizers) or expensive reagents can allow more people to perform the techniques at
reasonable costs. The majority of the economic cost of the project is borne by the
fluorescent weight markers that will act as indicators of standard pore size achievement.
Once standard protocols are established, the production of alginate microcapsules with
manipulable pore size will be relatively low-cost and straight forward.

Sustainability
Experimental methods should not generate waste or harmful byproducts or require
energy-intensive equipment. The devised setup for alginate microcapsule formation
primarily utilizes compressed air to produce uniform, replicable samples - a method with
no toxic by-products and minimal energy expenditure. Mechanical compression to
induce broken crosslinks ands subsequent increases in pore sizes using a Mach-1
system generates no additional waste.
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Health & Safety
Proposed methods of alginate microcapsules carry minimal health and safety risks to
both manufacturer and customer. Minimal training in regard to handling compressed air
tanks, however, is required for capsule formation pursuant to the atomization setup in
use. Because alginate is a biocompatible material, it presents no biological risk and
even has a number of potential in vivo applications. Other in vitro applications involving
alginate microcapsules with modifiable pore sizes could actually promote global human
health by acting as non-cytotoxic cell viability assays for experiment drugs or
biomolecular therapies.

Ethical
Accommodating wider ranges of alginate hydrogel pore sizes enable toolkit
development for a variety of biomedical applications. Such applications could promote
human health, such as target drug delivery, or allow for easier and faster evaluation of
biomolecular therapies or interventions, such as cytotoxicity testing. By enabling a
cheaper, more efficient testing mechanism to aid in the development of therapies or
pharmaceuticals, the project demonstrates its ethical value to not only the biomedical
field, but to society as a whole.
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Appendices

Appendix 1. Supplemental Figures and Tables
Appendix 1.1. Estimated Budget for Project

Item

Preliminary Cost

Reagents
Alginate

$180

Crosslinking agents

$145

Chemical modifiers

$95

Size markers

$610

Equipment
Flowmeter + Needles

$1,140

Mach-1

-

Imaging equipment

-

Total

$2,170
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Appendix 1.2. Membrane diffusivity as a function of solute to membrane pore size [1]

Appendix 1.3. Summary of atomization parameters, bead sizes and dimensionless
numbers [33]
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Appendix 1.4. Effect of AFM scan area on apparent pore size [1]

Appendix 1.5. Probability densities of macrobead metrics. Data was analyzed for normality and
processed using the Gaussian probability density function. A) 4 kDa FITC-dextran; B) 70 kDa
FITC-dextran; C) 26 nm polystyrene; D) 47 nm polystyrene
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